PMC:7279430 / 43820-43985 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T138","span":{"begin":98,"end":103},"obj":"Body_part"}],"attributes":[{"id":"A138","pred":"fma_id","subj":"T138","obj":"http://purl.org/sig/ont/fma/fma68646"}],"text":"1,8-cineole (33.9%), terpinen-4-ol (18.8%), and γ-terpinene (10.4%) Plaque reduction assay (Vero cells), HSV-1 99% plaque reduction (concentration not given) [66]"}

{"project":"LitCovid-PubTator","denotations":[{"id":"2301","span":{"begin":106,"end":111},"obj":"Species"},{"id":"2564","span":{"begin":0,"end":11},"obj":"Chemical"},{"id":"2565","span":{"begin":21,"end":34},"obj":"Chemical"},{"id":"2566","span":{"begin":48,"end":59},"obj":"Chemical"}],"attributes":[{"id":"A2301","pred":"tao:has_database_id","subj":"2301","obj":"Tax:10298"},{"id":"A2564","pred":"tao:has_database_id","subj":"2564","obj":"MESH:D000077591"},{"id":"A2565","pred":"tao:has_database_id","subj":"2565","obj":"MESH:C034019"},{"id":"A2566","pred":"tao:has_database_id","subj":"2566","obj":"MESH:C018669"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"1,8-cineole (33.9%), terpinen-4-ol (18.8%), and γ-terpinene (10.4%) Plaque reduction assay (Vero cells), HSV-1 99% plaque reduction (concentration not given) [66]"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T480","span":{"begin":93,"end":97},"obj":"http://purl.obolibrary.org/obo/CLO_0009524"},{"id":"T481","span":{"begin":93,"end":97},"obj":"http://purl.obolibrary.org/obo/CLO_0050515"},{"id":"T482","span":{"begin":98,"end":103},"obj":"http://purl.obolibrary.org/obo/GO_0005623"}],"text":"1,8-cineole (33.9%), terpinen-4-ol (18.8%), and γ-terpinene (10.4%) Plaque reduction assay (Vero cells), HSV-1 99% plaque reduction (concentration not given) [66]"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T782","span":{"begin":0,"end":11},"obj":"Chemical"},{"id":"T783","span":{"begin":4,"end":11},"obj":"Chemical"}],"attributes":[{"id":"A782","pred":"chebi_id","subj":"T782","obj":"http://purl.obolibrary.org/obo/CHEBI_27961"},{"id":"A783","pred":"chebi_id","subj":"T783","obj":"http://purl.obolibrary.org/obo/CHEBI_23243"}],"text":"1,8-cineole (33.9%), terpinen-4-ol (18.8%), and γ-terpinene (10.4%) Plaque reduction assay (Vero cells), HSV-1 99% plaque reduction (concentration not given) [66]"}

{"project":"LitCovid-sentences","denotations":[{"id":"T353","span":{"begin":0,"end":165},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"1,8-cineole (33.9%), terpinen-4-ol (18.8%), and γ-terpinene (10.4%) Plaque reduction assay (Vero cells), HSV-1 99% plaque reduction (concentration not given) [66]"}